Article Text

Download PDFPDF
Hypoglycaemia and neonatal brain injury
  1. James P Boardman1,
  2. Courtney J Wusthoff2,
  3. Frances M Cowan3
  1. 1MRC Centre for Reproductive Health, The University of Edinburgh, Queen's Medical Research Institute, Edinburgh, UK
  2. 2Division of Child Neurology, Stanford University, Palo Alto, USA
  3. 3Department of Paediatrics, Imperial College London, London, UK
  1. Correspondence to Dr James P Boardman, MRC Centre for Reproductive Health, The University of Edinburgh, Queen's Medical Research Institute, Room C1.20, 47 Little France Crescent, Edinburgh EH16 4TJ, UK; james.boardman{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


The level of blood glucose (BG) concentration that leads to cerebral injury in newborns and adverse neurodevelopmental outcome is unknown: low BG is observed during postnatal adaptation of healthy term infants without apparent adverse consequence, and the capacity to mobilise and use alternative cerebral fuels when BG is low varies between patient groups.1 Because of this uncertainty an ‘operational threshold’ approach to the management of neonates with hypoglycaemia has been proposed, which defines ‘the concentration of plasma or whole BG at which clinicians should intervene based on evidence currently available in the literature.’ In this model infants at risk of neurological sequelae from hypoglycaemia are identified (see algorithm), and interventions to raise the BG are recommended at specified thresholds, with the caveat that acute neurological dysfunction in association with low BG at any level should prompt urgent investigation and treatment.2

A review of the literature supports the previous consensus that BG levels below 1.0 mmol/l that are persistent beyond 1–2 h (or are recurrent) and are associated with acute neurological dysfunction present the greatest risk for cerebral injury, and that brief episodes of hypoglycaemia in the absence of acute neurological dysfunction or an associated disorder are less likely to lead to cerebral injury and poor outcome.3

The spectrum of cerebral injury associated with hypoglycaemia is wide and includes: white matter injury including parenchymal haemorrhage and ischaemic stroke, cortical neuronal injury, and sometimes signal change in the basal ganglia (mainly the globus pallidus) and thalami4–15 (figure 1). Vulnerability of the white matter and cortex of the posterior parietal and occipital lobes has been well reported in human imaging studies,6 ,13 ,16 but the site of injury is more widespread in pathological and experimental studies of neonatal hypoglycaemia.4 ,5 ,17 In the largest series …

View Full Text


  • Contributors JPB and FC wrote the review and designed the algorithm. CW provided important intellectual content, and all authors approved the submitted version.

  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.